Pretransplant-corrected QT dispersion as a predictor of pericardial effusion after pediatric hematopoietic stem cell transplantation. - Wikidata - awgldk - TriplyDB

Pretransplant-corrected QT dispersion as a predictor of pericardial effusion after pediatric hematopoietic stem cell transplantation.

Pretransplant-corrected QT dispersion as a predictor of pericardial effusion after pediatric hematopoietic stem cell transplantation.

http://www.wikidata.org/entity/Q33420131

about

New approaches in the diagnosis, pathophysiology, and treatment of pediatric hematopoietic stem cell transplantation-associated thrombotic microangiopathy.

P2860

Q33432069-14B4E1DB-81B5-4F62-A43A-1889F59CFCAB

P2860

Pretransplant-corrected QT dispersion as a predictor of pericardial effusion after pediatric hematopoietic stem cell transplantation.

http://www.wikidata.org/entity/Q33420131

description

2015 nî lūn-bûn

@nan

2015 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2015 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

name

Pretransplant-corrected QT dis ...... tic stem cell transplantation.

@ast

Pretransplant-corrected QT dis ...... tic stem cell transplantation.

@en

type

label

Pretransplant-corrected QT dis ...... tic stem cell transplantation.

@ast

Pretransplant-corrected QT dis ...... tic stem cell transplantation.

@en

prefLabel

Pretransplant-corrected QT dis ...... tic stem cell transplantation.

@ast

Pretransplant-corrected QT dis ...... tic stem cell transplantation.

@en

P1433

Q33420131-6D02260F-D11B-4671-AF14-F99C30EAC8F3

P1476

Q33420131-E2C9BB3A-056E-481C-AA95-33C864BBAB13

P2093

Q33420131-028403B0-1C80-4056-85AF-61B7DB7A856D

Q33420131-34730AE5-B137-4117-8F30-B8A0706036F4

Q33420131-3C5F430A-984D-4B5F-AEC3-276F68D843DC

Q33420131-41EDD00F-6AA8-48C7-AC43-C4D07E4F5748

Q33420131-50216026-45CB-4927-8938-70AAFC9A05FA

Q33420131-679D670D-A88C-45CF-BA83-02891BF9558B

Q33420131-6A7670BA-9BFB-461E-A08D-2AAEA25F13A7

Q33420131-98E91086-18A0-419E-B68D-ECC50C9D578B

Q33420131-AAA64ADC-AEDD-4897-BCAB-80C7CA7034A2

Q33420131-AB5CD8E2-8F69-4F4D-8629-9C0F7E2D1689

P2860

Q33420131-0FFF2F1F-17CB-41E3-9536-676D4540C4D7

Q33420131-12E7F967-6737-44F1-BADD-550320DCCD42

Q33420131-1871D67C-7467-42D0-B00C-60BCAE9B83B4

Q33420131-22754C53-BA44-4691-84EE-404E87FB7D2C

Q33420131-29B0A3D3-FB93-488E-B418-18B4D5B6B35B

Q33420131-4E8CDE4E-4857-41A6-A235-0A7FB37BEA21

Q33420131-5E4FA0A2-AEDA-434C-8E52-4F2E41A44211

Q33420131-6F4A3908-B485-4492-B9C6-491A34218E81

Q33420131-92F04BBB-D961-4FA2-AE2F-F47B89CC2C91

Q33420131-935C0D30-89C7-42D3-B8D1-D37CB15BF7B5

P304

Q33420131-72278DB3-D679-4EF2-B905-2AB3636A89CF

P31

Q33420131-E0AB214B-C49B-4CBA-9E4F-CCB45BCA5D1D

P356

Q33420131-84257874-5F86-45CA-9287-DC8DAF510228

P433

Q33420131-96F707A7-E912-418A-9929-283B88FB8044

P478

Q33420131-F3A375F5-3CCB-4E78-BF44-7885CB6BA0BA

P577

Q33420131-CCF380D6-FBD2-4434-B388-FA8FD0DDBFD4

P698

Q33420131-726FD7C1-3903-4239-A13E-17A957A895D4

P356

P1433

Transplant International

P1476

Pretransplant-corrected QT dis ...... tic stem cell transplantation.

@en

P2093

Daisuke Morita

http://www.w3.org/2001/XMLSchema#string

Eiko Hidaka

http://www.w3.org/2001/XMLSchema#string

Eizaburo Ishii

http://www.w3.org/2001/XMLSchema#string

Kazuo Sakashita

http://www.w3.org/2001/XMLSchema#string

Masaaki Shiohara

http://www.w3.org/2001/XMLSchema#string

Miyuki Tanaka

http://www.w3.org/2001/XMLSchema#string

Noriko Kubota

http://www.w3.org/2001/XMLSchema#string

Noriko Motoki

http://www.w3.org/2001/XMLSchema#string

Ryu Yanagisawa

http://www.w3.org/2001/XMLSchema#string

Satoshi Yasukochi

http://www.w3.org/2001/XMLSchema#string

P2860

QT dispersion as a predictor of acute heart failure after high-dose cyclophosphamide

Blood and marrow transplant clinical trials network toxicity committee consensus summary: thrombotic microangiopathy after hematopoietic stem cell transplantation.

Diagnostic criteria for hematopoietic stem cell transplant-associated microangiopathy: results of a consensus process by an International Working Group.

Hemolytic-uremic syndrome and myocardial dysfunction in a 9-month-old boy.

Diagnosis and treatment of transplantation-associated thrombotic microangiopathy: real progress or are we still waiting?

Comparison of thrombotic microangiopathy after allogeneic hematopoietic cell transplantation with high-dose or nonmyeloablative conditioning.

Myocardial infarction is a complication of factor H-associated atypical HUS.

Small vessels, big trouble in the kidneys and beyond: hematopoietic stem cell transplantation-associated thrombotic microangiopathy.

Abnormal echocardiography 7 days after stem cell transplantation may be an early indicator of thrombotic microangiopathy.

Hemolytic uremic syndrome after allogeneic or autologous hematopoietic stem cell transplantation for childhood malignancies.

P304

565-574

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/TRI.12532

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

28

http://www.w3.org/2001/XMLSchema#string

P577

2015-02-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25644234

http://www.w3.org/2001/XMLSchema#string